China Biologic Products (CBPO) Tops Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. NVDA
6. MSFT
7. SPY
8. SKYD
9. GOOGL
10. BBIO

Go back to China Biologic Products (CBPO) Tops Q4 EPS by 1c

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017

February 28, 2018 5:00 PM EST

BEIJING, Feb. 28, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2017.

Fourth Quarter 2017 Financial Highlights

Total sales in the fourth quarter of 2017 increased by 12.2% in RMB terms and 16.1% in USD terms to $90.1 million from $77.6 million in the same quarter of 2016. Gross profit increased by 26.7% to $59.3 million from $46.8 million in the same quarter of 2016. Gross margin increased to 65.8% from 60.3% in the... More